+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Atrion Corp (ATRI) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 42 Pages
  • April 2023
  • GlobalData
  • ID: 4285096
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Atrion Corp (ATRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Atrion Corp (Atrion) develops and manufactures products related to fluid delivery, cardiovascular, ophthalmic, and other medical and non-medical products. The company’s portfolio spans across proprietary valves, silicone vessel loops, myocardial protection system, inflation devices, medical devices that disinfect contact lenses, balloon catheters, and products used in heart bypass surgery. Atrion also offers products for safe needle and scalpel blade containment, instrumentation and related disposables for measuring the clotting time of blood, inflation systems and valves for aviation and marine safety products, one-way and two-way pressure relief valves, and components used in inflatable survival products and structures. It sells its products to physicians, clinics, hospitals, and other treatment centers. It has direct operations in Texas, Delaware and Alabama. Atrion is headquartered in Allen, Texas, the US.

Atrion Corp Key Recent Developments

  • Feb 27, 2023: Atrion Reports Fourth Quarter and Full Year 2022 Results
  • Nov 08, 2022: Atrion Reports Third Quarter 2022 Results
  • Aug 25, 2022: Atrion Announces CFO Succession Plan
  • Aug 08, 2022: Atrion Reports Second Quarter 2022 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Atrion Corp - Key Facts
  • Atrion Corp - Key Employees
  • Atrion Corp - Key Employee Biographies
  • Atrion Corp - Major Products and Services
  • Atrion Corp - History
  • Atrion Corp - Company Statement
  • Atrion Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Atrion Corp - Business Description
  • Product Category: Cardiovascular
  • Overview
  • Performance
  • Product Category: Fluid Delivery
  • Overview
  • Performance
  • Product Category: Ophthalmology
  • Overview
  • Performance
  • Product Category: Other
  • Overview
  • Performance
  • Geographical Segment: All other regions
  • Performance
  • Geographical Segment: European Union
  • Performance
  • Geographical Segment: United States
  • Performance
  • R&D Overview
  • Atrion Corp - Corporate Strategy
  • Atrion Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Atrion Corp - Strengths
  • Atrion Corp - Weaknesses
  • Atrion Corp - Opportunities
  • Atrion Corp - Threats
  • Atrion Corp - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Recent Developments
  • Feb 27, 2023: Atrion Reports Fourth Quarter and Full Year 2022 Results
  • Nov 08, 2022: Atrion Reports Third Quarter 2022 Results
  • Aug 25, 2022: Atrion Announces CFO Succession Plan
  • Aug 08, 2022: Atrion Reports Second Quarter 2022 Results
  • May 09, 2022: Atrion Reports First Quarter 2022 Results
  • Feb 25, 2022: Atrion Reports Fourth Quarter and Full Year 2021 Results
  • Jan 10, 2022: Atrion Reports Results for Fourth Quarter and Full Year 2020
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Atrion Corp, Key Facts
  • Atrion Corp, Key Employees
  • Atrion Corp, Key Employee Biographies
  • Atrion Corp, Major Products and Services
  • Atrion Corp, History
  • Atrion Corp, Subsidiaries
  • Atrion Corp, Key Competitors
  • Atrion Corp, Ratios based on current share price
  • Atrion Corp, Annual Ratios
  • Atrion Corp, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Atrion Corp, Performance Chart (2018 - 2022)
  • Atrion Corp, Ratio Charts

Companies Mentioned

A selection of companies mentioned in this report includes:

  • The Cooper Companies Inc
  • InfuSystem Holdings Inc
  • Transcat Inc
  • Boston Scientific Corp
  • Avinger Inc
  • Medtronic Plc
  • Cardiovascular Systems Inc